Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience-Reference-Cited by-同舟云学术

Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

Published:2018-06 Issue:3 Volume:2 Page:e44
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Alduaij Waleed,McNamara Caroline J.,Schuh Andre,Arruda Andrea,Sukhai Mahadeo,Kanwar Nisha,Thomas Mariam,Spiegel Jay,Kennedy James A.,Stockley Tracy,Tsui Hubert,Devlin Rebecca,Sibai Hassan,Maze Dawn,Schimmer Aaron,Yee Karen,Chan Steven,Kamel-Reid Suzanne,Gupta Vikas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference27 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms;Rumi;Blood,2017

3. Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients;Cabagnols;Blood,2016

4. Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms;Milosevic Feenstra;Blood,2016

5. Mutations and prognosis in primary myelofibrosis;Vannucchi;Leukemia,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Raman Spectroscopy of Blood Serum for Essential Thrombocythemia Diagnosis: Correlation with Genetic Mutations and Optimization of Laser Wavelengths;Cell Biochemistry and Biophysics;2024-06-07

2. A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria;Blood Advances;2024-03-29

3. Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements;Cancers;2024-01-25

4. Molecular testing in myeloproliferative neoplasms;Diagnostic Molecular Pathology;2024

5. Molecular diagnostic criteria of myeloproliferative neoplasms;Expert Review of Molecular Diagnostics;2023-11-24